Computational tool developed to predict immunotherapy outcomes for patients with metastatic breast cancer

Using computational tools, researchers have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy.

Using computational tools, researchers have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy.

Read more https://www.sciencedaily.com/releases/2024/10/241029143819.htm